Model N Announces Third Quarter of Fiscal Year 2019 Financial Results
SAN MATEO, Calif.--(BUSINESS WIRE)--Model N, Inc., (NYSE: MODN), the leading provider of cloud revenue management solutions for life sciences and...
Day: August 6, 2019
CPSI Announces Second Quarter 2019 Results
Company Announces Quarterly Cash Dividend of $0.10 Per Share Highlights for Second Quarter 2019: Revenues of $66.2 million; GAAP net...
MorphoSys Discloses Biomarker to Stratify Patient Population in B-MIND Study of Tafasitamab plus Bendamustine in r/r DLBCL
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / August 6, 2019 / MorphoSys AG (FSE:MOR; Prime Standard Segment; MDAX & TecDAX; NASDAQ:MOR) today...
MorphoSys AG Reports Second Quarter 2019 Financial Results
MUNICH, GERMANY / ACCESSWIRE / August 6, 2019 / MorphoSys AG Reports Second Quarter 2019 Financial Results Conference call and...
Adial Pharmaceuticals’ Chief Executive Officer to be Featured Live on Cheddar’s ”Closing Bell”
CHARLOTTESVILLE, VA / ACCESSWIRE / August 6, 2019 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) (NASDAQ:ADILW), a clinical-stage biopharmaceutical company focused on...
MorphoSys Announces Intention to Submit Marketing Authorization Application for Tafasitamab to European Medicines Agency
PLANEGG and MUNICH, GERMANY / ACCESSWIRE / August 6, 2019 / MorphoSys AG (FSE:MOR) (Prime Standard Segment:MDAX) (Prime Standard Segment:TecDAX)...
ReShape Lifesciences Announces CFO Resignation
SAN CLEMENTE, CA / ACCESSWIRE / August 6, 2019 / ReShape Lifesciences Inc. (OTCQB:RSLS), a developer of minimally invasive medical...
Kyruus ProviderMatch® Patient Access Platform Now Powering Patient-Provider Matching at Norton Healthcare
Kyruus Platform Aims to Help Kentucky Health System Empower Consumers and Streamline Access BOSTON--(BUSINESS WIRE)--Kyruus, the leader in provider search...
International Cannabrands CEO Steve Gormley Provides Letter to Shareholders
CALGARY, AB / ACCESSWIRE / August 6, 2019 / International Cannabrands Inc. (CSE:JUJU) (the “Company” or “ICI”) shared CEO Steve...
Serenas Lawsuit Amended to Remove Claim for 10,270,437 Shares or $5,546,035 as Against Experion Holdings Ltd
VANCOUVER, BC / ACCESSWIRE / August 6, 2019 / Experion Holdings Ltd. (“Experion” or the “Company”) (TSXV:EXP)(OTCQB:EXPFF) (Frankfurt: MB31), formerly...
Virpax(R) Pharmaceuticals to Present at the 2019 Military Health System Research Symposium
MALVERN, PA / ACCESSWIRE / August 6, 2019 / Virpax® Pharmaceuticals, Inc. (“Virpax”), a company specializing in developing pharmaceutical products...
Eviana Announces Termination of Intended Hemp Sale
TORONTO, ONTARIO / ACCESSWIRE / August 6, 2019 / Eviana Health Corporation (the “Company”) (CNSX:EHC)(OTC PINK:EVNNF) announces the termination of...
Soricimed Announces Investigator Initiated Phase 1b Clinical trial of its Lead Drug Candidate in Late-Stage Pancreatic Cancer
TORONTO, CANADA / ACCESSWIRE / AUGUST 6, 2019 / Soricimed Biopharma Inc. ("Soricimed"), a clinical-stage pharmaceutical company developing first-in-class, targeted...
ITOCO Signs Letter Of Intent For Hemp Biomass Production With PROHEMP COLOMBIA SAS
TORONTO, ON / ACCESSWIRE / August 6, 2019 / ITOCO INC. (OTC PINK:ITMC) is pleased to announce it has signed...
Netsmart Technology Boosts Census and Bottom Line with Electronic Referral Management
OVERLAND PARK, Kan.--(BUSINESS WIRE)--Cantex Continuing Care Network (Cantex) and Diakon Lutheran Social Ministries (Diakon), together with Netsmart, have announced the...
joimax® and Red One Medical Partner to Support Expert Endoscopic Minimally Invasive Spine Surgery for Veterans and Active Military
SAVANNAH, Ga.--(BUSINESS WIRE)--joimax®, a leading developer and marketer of complete systems for endoscopic minimally invasive spinal surgery, and Red One...
MEDITECH Celebrates 50 Years of Healthcare Technology Innovation
Enterprise Health Record (EHR) trailblazer remains focused on the future WESTWOOD, Mass.--(BUSINESS WIRE)--MEDITECH, a leading Enterprise Health Record (EHR) vendor,...
Alnylam Pharmaceuticals Reports Second Quarter 2019 Financial Results and Highlights Recent Period Activity
− Achieved Second Quarter 2019 ONPATTRO® Global Net Product Revenues of $38.2 Million with More Than 500 Patients on Commercial...